Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.006 Å; R factor = 0.055; wR factor = 0.166; data-to-parameter ratio = 14.2.
In the title compound, C 16 H 14 N 2 OS, the quinazoline ring system is essentially planar, with a maximum deviation of 0.029 (3) Å . The dihedral angle between the quinazoline and benzene rings is 88.4 (2) . In the crystal, adjacent molecules are connected via pairs of N-HÁ Á ÁS and C-HÁ Á ÁO hydrogen bonds, which generate R 2 2 (8) and R 2 2 (10) graph-set motifs, respectively, resulting in a supramolecular chain along the a axis.
Related literature
For details and applications of quinazoline compounds, see: Roth & Fenner (2000) ; Jantova et al. (2004) ; Harris & Thorarensen (2004) ; Andries et al. (2005) ; Al- Rashood et al. (2006) ; Ghorab et al. (2007) ; Rá dl et al. (2000) ; Klepser & Klepser (1997) ; Al-Omar et al. (2004) ; Al-Omary et al. (2010) . For hydrogen-bond motifs, see: Bernstein et al. (1995) . For bondlength data, see: Allen et al. (1987) Table 1 Hydrogen-bond geometry (Å , ).
Symmetry codes: (i) Àx þ 1 2 ; Ày þ 1 2 ; Àz; (ii) Àx; Ày þ 2; Àz.
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 
Kun Fun Comment
Quinazoline moiety is present in many classes of biologically-active compounds. A number of them have been clinically used as antifungal, antibacterial and antiprotozoic drugs (Roth & Fenner, 2000; Jantova et al., 2004; Harris & Thorarensen, 2004) , as well as antituberculotic agents (Andries et al., 2005) . Furthermore, they have drawn much attention due to their broad range of pharmacological properties which include antitumor (Al-Rashood et al., 2006) , anticancer (Ghorab et al., 2007) and analgesic (Rádl et al., 2000) properties. Certain quinazoline analogs also showed remarkable activity against the opportunistic infections of Pneumocystis carinii and Toxoplasma gondii. Those microorganisms proved to be the priniciple cause of death in patients with immunocompromised diseases such as acquired immune deficiency syndrome (Klepser & Klepser, 1997) . This work is a continuation of this program with the aim of obtaining an interesting series of quinazolines that contain the thioxo functional group which was identified as a possible pharmacophore of the antimicrobial activity (Al-Omar et al., 2004; Al-Omary et al., 2010) .
The molecular structure of the title compound is shown in Fig. 1 . The quinazoline (N1,N2/C1-C8) ring is essentially planar, with a maximum deviation of 0.029 (3) Å for atom C2. The dihedral angle between the quinazoline (N1,N2/C1-C8) and the benzene (C10-C15) rings is 88.4 (2)°. The bond lengths (Allen et al., 1987) and angles are within normal ranges. In the crystal, (Fig. 2) , the adjacent molecules are connected via a pair of N-H···S and C-H···O (Table 1) hydrogen bonds, generating R 2 2 (8) and R 2 2 (10) graph-set motifs (Bernstein et al., 1995) , respectively, resulting in a supramolecular [100] chain.
Experimental
A mixture of benzyl isothiocyanate (10 mmol) and 2-amino-5-methyl benzoic acid (10 mmol) in ethanol (30 ml) was heated under reflux in the presence of triethylamine (5 mmol) for 2 h. After cooling, the mixture was poured into ice/water. The resulting solid was filtered, washed with water and dried. Recrystallization from ethanol gave 3benzyl-2,3-dihydro-6-methyl-2-thioxo-quinazoline-4(1H)-one as colorless crystals.
Refinement
All H atoms were positioned geometrically (N-H = 0.86 Å and C-H = 0.93-0.97 Å) and were refined using a riding model, with U iso (H) = 1.2 or 1.5U eq (C). A rotating group model was applied to the methyl groups.
Computing details
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT (Bruker, 2009 ); program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009 The molecular structure of the title compound, showing 30% probability displacement ellipsoids.
Figure 2
The crystal packing view of the title compound along the b axis. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
3-Benzyl-6-methyl-2-sulfanylidene-2,3-dihydroquinazolin-4(1H)-one

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq S1 0.22029 (4) 0.1447 (2) 0.07055 (4) 0.0718 (3) N1 0.17921 (10) 0.4985 (6) −0.01167 (11) 0.0630 (7) 
